Literature DB >> 2219668

Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease.

V P Gannon1, C L Gyles.   

Abstract

Shiga-like toxin (SLT-IIv) from Escherichia coli strains associated with edema disease of pigs was characterized and compared with SLT-I, SLT-II, and the SLT of E. coli strain HI8 (SLT-HI8). SLT-IIv from an E. coli K12 in which the genes for SLT-IIv had been cloned was indistinguishable from SLT-IIv of wild strains of E. coli from edema disease. There was cross-neutralization among all SLTs except SLT-I. The different SLTs could be distinguished by heat lability, with the descending order of heat lability being SLT-IIv, SLT-II, SLT-I, and SLT-HI8. SLT-IIv and SLT-HI8 had lower cytotoxic titers on HeLa cells compared with Vero cells and were more active on MDBK cells than were the other SLTs. All SLTs were enterotoxic in rabbit but not in pig intestine and SLT-IIv was less enterotoxic than SLT-I. SLT-IIv had a lower LD50 in mice than did the other SLTs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219668     DOI: 10.1016/0378-1135(90)90054-y

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  16 in total

1.  Antigenic recombinant proteins expressed in tobacco seeds as a model for edible vaccines against swine oedema.

Authors:  L Rossi; A Baldi; V Dell'Orto; C Fogher
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle.

Authors:  Kim N Brett; Vidiya Ramachandran; Michael A Hornitzky; Karl A Bettelheim; Mark J Walker; Steven P Djordjevic
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli.

Authors:  H Schmidt; W L Zhang; U Hemmrich; S Jelacic; W Brunder; P I Tarr; U Dobrindt; J Hacker; H Karch
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Pathogenic Shiga toxin-producing Escherichia coli in the intestine of calves.

Authors:  K S Sandhu; C L Gyles
Journal:  Can J Vet Res       Date:  2002-04       Impact factor: 1.310

5.  Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles; A Valdivieso-Garcia; R C Clarke
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7.

Authors:  A Suzuki; H Doi; F Matsuzawa; S Aikawa; K Takiguchi; H Kawano; M Hayashida; S Ohno
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

7.  Sodium deoxycholate facilitates systemic absorption of verotoxin 2e from pig intestine.

Authors:  T E Waddell; C L Gyles
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Mitomycin-induced synthesis of a Shiga-like toxin from enteropathogenic Escherichia coli H.I.8.

Authors:  A J Yee; S De Grandis; C L Gyles
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin.

Authors:  S Franke; D Harmsen; A Caprioli; D Pierard; L H Wieler; H Karch
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets.

Authors:  Luciana Rossi; Vittorio Dell'Orto; Simona Vagni; Vittorio Sala; Serena Reggi; Antonella Baldi
Journal:  Vet Res Commun       Date:  2013-11-19       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.